Wednesday, 16 July 2014

Novartis to license Google "smart lens" technology

Helping diabetic patients manage their disease by providing a continuous, minimally invasive measurement of the body's glucose levels via a "smart contact lens" which is designed to measure tear fluid in the eye and connects wirelessly with a mobile device (Novartis)


Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients

Circulating concentrations of betatrophin are significantly increased in T2DM patients. Our results suggest that betatrophin may play a role in the pathogenesis of T2DM (Diabetes Care)

No comments:

Post a Comment